Efficacy of Antenatal Steroids in Reducing Respiratory Morbidities in Late Preterm Infants

• Status: Unknown status
• Trial end date: 2013-09-01
• Target enrollment: 0
• Participant gender: Female

Summary

The hypothesis of the study is that administration of antenatal steroid to women at high risk of preterm birth after 34 weeks of gestation would reduce the risk of respiratory complications, specifically Respiratory Distress Syndrome (RDS) or Transient Tachypnea of the Newborn (TTN) in late preterm babies.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: American University of Beirut Medical Center
• Treatments: Betamethasone; Betamethasone benzoate; Betamethasone sodium phosphate; Betamethasone Valerate; Betamethasone-17,21-dipropionate

Criteria

Inclusion Criteria:

• Women between 34 0/7- 36 6/7 weeks of gestation

• High risk of preterm birth

Exclusion Criteria:

• Multiple births

• Fetal congenital malformations

• A course of steroids within 2 weeks of randomization

• Multiple courses of steroids

• Chorioamnionitis

• Non reassuring fetal heart rate

• Obstetrical indication of delivery

• Active bleeding

• Pregnancy related hypertensive disorders

• Uncontrolled diabetes